在前列腺癌中PSMA PET/CT的预后价值
Ismaheel O Lawal1, Honest Ndlovu2, Mankgopo Kgatle2
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa.
Seminars in nuclear medicine
|July 23, 2023
概括
前列腺特异性膜抗原 (PSMA) 成像对于前列腺癌 (PCa) 管理至关重要. PSMA PET扫描精确检测PCa,预测结果,并指导治疗,特别是在复发和晚期疾病.
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 放射化学 放射化学是指辐射化学.
背景情况:
- 前列腺特异性膜抗原 (PSMA) 是一种在大多数前列腺癌 (PCa) 中过度表达的糖蛋白.
- PSMA的酶活性影响PCa细胞代谢和侵略性表型.
- 它的细胞外域是诊断和治疗剂的目标,使得theranostics.
研究的目的:
- 审查PSMA PET成像在前列腺癌管理中的预后和治疗效用.
- 突出PSMA PET在各种临床环境中的作用,从诊断到晚期疾病.
- 探索人工智能在分析PSMA PET图像方面的潜力,以改善预后.
主要方法:
- 对前列腺癌中PSMA PET成像现有文献的综述.
- 分析PSMA PET在预剖检,分期,生化复发和晚期疾病设置中的性能.
- 在PSMA PET成像中讨论PSMA向的放射性干疗法和AI应用.
主要成果:
- PSMA PET准确地识别出临床意义上的PCa,在分期中优于传统成像,并且对于检测生化复发非常敏感.
- PSMA热情与PCa攻击性和治疗后的结果相关.
- PSMA PET 预测了对各种疗法的治疗反应,包括放射性连接体疗法,复发模式为预后提供了信息.
结论:
- PSMA PET成像是一种多功能工具,在前列腺癌管理中具有显著的预后和治疗意义.
- 它在指导救援疗法和预测治疗反应方面的应用是非常宝贵的.
- 人工智能与PSMA PET成像的整合为增强PCa预测提供了未来的潜力.
相关概念视频
Positron Emission Tomography
4.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.3K
Sensitivity, Specificity, and Predicted Value
492
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
492


